Medical device recalls: February 2022
The FDA posted 22 medical device recall records in February 2022, from 10 recall events by 10 companies. 12 are Class I, the most serious category.
Each product in a recall gets its own record, so one recall event can cover several records. What recall classes mean.
Companies with the most recall events
- Teleflex Medical Inc · 1 event, 7 records, 7 Class I
- Microbiologics Inc · 1 event, 5 records
- Collagen Matrix, Inc. · 1 event, 2 records
- Respironics California, LLC · 1 event, 2 records, 2 Class I
- Abiomed, Inc. · 1 event, 1 record, 1 Class I
- Becton Dickinson & Co. · 1 event, 1 record
- Covidien Llc · 1 event, 1 record
- E25Bio, Inc. · 1 event, 1 record, 1 Class I
FDA root cause
- Process change control · 7
- Process design · 5
- Under Investigation by firm · 2
- Process control · 2
- Nonconforming Material/Component · 2
- Software design (manufacturing process) · 1
- Software change control · 1
- No Marketing Application · 1
Class I recalls (12)
The most serious: a reasonable probability that using the device will cause serious health problems or death.
- Z-0662-2022 · Respironics California, LLC · posted Feb 25, 2022 · Open, Classified
A limited number of ventilators were assembled with expired adhesive. If the adhesive fails, a bracket may become loose and potentially damage the capacitors, which could cause the ventilator to stop providing ventilation to the patient. This failure may…
- Z-0663-2022 · Respironics California, LLC · posted Feb 25, 2022 · Open, Classified
A limited number of ventilators were assembled with expired adhesive. If the adhesive fails, a bracket may become loose and potentially damage the capacitors, which could cause the ventilator to stop providing ventilation to the patient. This failure may…
- bellavista 1000 ventilator, Catalog #301.100.030 and bellavista 1000e ventilator, 301.100.130.Class IZ-0622-2022 · Vyaire Medical · posted Feb 16, 2022 · Terminated
Potential cessation in ventilation can occur under specific conditions.
- Z-0623-2022 · Teleflex Medical Inc · posted Feb 15, 2022 · Terminated
The firm received reports indicating PTD tip separation during use.
- Z-0624-2022 · Teleflex Medical Inc · posted Feb 15, 2022 · Terminated
The firm received reports indicating PTD tip separation during use.
- Z-0625-2022 · Teleflex Medical Inc · posted Feb 15, 2022 · Terminated
The firm received reports indicating PTD tip separation during use.
- Z-0626-2022 · Teleflex Medical Inc · posted Feb 15, 2022 · Terminated
The firm received reports indicating PTD tip separation during use.
- Z-0627-2022 · Teleflex Medical Inc · posted Feb 15, 2022 · Terminated
The firm received reports indicating PTD tip separation during use.
- Z-0628-2022 · Teleflex Medical Inc · posted Feb 15, 2022 · Terminated
The firm received reports indicating PTD tip separation during use.
- Z-0629-2022 · Teleflex Medical Inc · posted Feb 15, 2022 · Terminated
The firm received reports indicating PTD tip separation during use.
- Z-0564-2022 · E25Bio, Inc. · posted Feb 9, 2022 · Terminated
The Test is not authorized, cleared, or approved by FDA for clinical diagnostic or screening purposes. It was distributed without sufficient directions or controls in place.
- Z-0550-2022 · Abiomed, Inc. · posted Feb 3, 2022 · Terminated
The firm has received complaints of the OXY-1 System Console experiencing a power interruption while in use, which disrupts therapy delivered to a patient on support. Disruption of therapy could lead to prolonged hypoxia.
Class II recalls (10)
The device may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
- Z-0668-2022 · Collagen Matrix, Inc. · posted Feb 24, 2022 · Terminated
Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
- Z-0669-2022 · Collagen Matrix, Inc. · posted Feb 24, 2022 · Terminated
Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
- Z-0653-2022 · Smiths Medical ASD Inc. · posted Feb 17, 2022 · Open, Classified
There have been intermittent issues with Supercap POST (power on self-test) and Backup Audible Alarm error codes outside of the pump warranty period. These alarms occur at start up when the pump goes through the self-test. This recall occurred in 2015.
- Z-0630-2022 · Becton Dickinson & Co. · posted Feb 9, 2022 · Open, Classified
May have the potential to overheat and/or cause fire, the issue can occur when an unauthorized alternative AC power adapter, and not the one provided by BD is used to power the instrument.
- Z-0585-2022 · Microbiologics Inc · posted Feb 8, 2022 · Terminated
Tests returning incorrect susceptible results. High Level Gentamicin Synergy value was out of specification (sensitive) when analyzed on the Vitek 2 AST-GP67 card, and these lots failed the disk diffusion method used for product release.
- LYFO-DISK Enterococcus faecalis derived from ATCC 51299 In Vitro Diagnostic Control microorganismsClass IIZ-0586-2022 · Microbiologics Inc · posted Feb 8, 2022 · Terminated
Tests returning incorrect susceptible results. High Level Gentamicin Synergy value was out of specification (sensitive) when analyzed on the Vitek 2 AST-GP67 card, and these lots failed the disk diffusion method used for product release.
- Z-0587-2022 · Microbiologics Inc · posted Feb 8, 2022 · Terminated
Tests returning incorrect susceptible results. High Level Gentamicin Synergy value was out of specification (sensitive) when analyzed on the Vitek 2 AST-GP67 card, and these lots failed the disk diffusion method used for product release.
- Z-0588-2022 · Microbiologics Inc · posted Feb 8, 2022 · Terminated
Tests returning incorrect susceptible results. High Level Gentamicin Synergy value was out of specification (sensitive) when analyzed on the Vitek 2 AST-GP67 card, and these lots failed the disk diffusion method used for product release.
- Z-0589-2022 · Microbiologics Inc · posted Feb 8, 2022 · Terminated
Tests returning incorrect susceptible results. High Level Gentamicin Synergy value was out of specification (sensitive) when analyzed on the Vitek 2 AST-GP67 card, and these lots failed the disk diffusion method used for product release.
- Z-0557-2022 · Covidien Llc · posted Feb 3, 2022 · Open, Classified
The firm has received six (6) complaint reports from customers indicating difficulty removing the balloon protector sleeve from the catheter (e.g., excessive force required to remove the protector sleeve). If the balloon is damaged while removing the…
Source: FDA Medical Device Recalls and FDA enforcement reports (recall class), via openFDA. Records are grouped by the date the FDA posted them. Methodology · Not medical advice.